362 related articles for article (PubMed ID: 17082591)
21. Involvement of CD73 (ecto-5'-nucleotidase) in adenosine generation by human gingival fibroblasts.
Hashikawa T; Takedachi M; Terakura M; Saho T; Yamada S; Thompson LF; Shimabukuro Y; Murakami S
J Dent Res; 2003 Nov; 82(11):888-92. PubMed ID: 14578500
[TBL] [Abstract][Full Text] [Related]
22. Activation of the aryl hydrocarbon receptor reduces the number of precursor and effector T cells, but preserves thymic CD4+CD25+Foxp3+ regulatory T cells.
Schulz VJ; Smit JJ; Bol-Schoenmakers M; van Duursen MB; van den Berg M; Pieters RH
Toxicol Lett; 2012 Nov; 215(2):100-9. PubMed ID: 23041608
[TBL] [Abstract][Full Text] [Related]
23. Cytokines affecting CD4(+) T regulatory cells in transplant tolerance. Interleukin-4 does not maintain alloantigen specific CD4(+)CD25(+) Treg.
Plain KM; Verma ND; Tran GT; Nomura M; Boyd R; Robinson CM; Hodgkinson SJ; Hall BM
Transpl Immunol; 2013 Dec; 29(1-4):51-9. PubMed ID: 24139939
[TBL] [Abstract][Full Text] [Related]
24. Functional tumor infiltrating TH1 and TH2 effectors in large early-stage cervical cancer are suppressed by regulatory T cells.
Adurthi S; Mukherjee G; Krishnamurthy H; Sudhir K; Bafna UD; Umadevi K; Jayshree RS
Int J Gynecol Cancer; 2012 Sep; 22(7):1130-7. PubMed ID: 22872166
[TBL] [Abstract][Full Text] [Related]
25. Phenotype of CD4+ T cell subsets that develop following mouse facial nerve axotomy.
Xin J; Wainwright DA; Serpe CJ; Sanders VM; Jones KJ
Brain Behav Immun; 2008 May; 22(4):528-37. PubMed ID: 18024079
[TBL] [Abstract][Full Text] [Related]
26. CD4+CD25+Foxp3+ T regulatory cells, Th1 (CCR5, IL-2, IFN-γ) and Th2 (CCR4, IL-4, Il-13) type chemokine receptors and intracellular cytokines in children with common variable immunodeficiency.
Kutukculer N; Azarsiz E; Aksu G; Karaca NE
Int J Immunopathol Pharmacol; 2016 Jun; 29(2):241-51. PubMed ID: 26684629
[TBL] [Abstract][Full Text] [Related]
27. Regulatory activity of human CD4 CD25 T cells depends on allergen concentration, type of allergen and atopy status of the donor.
Bellinghausen I; König B; Böttcher I; Knop J; Saloga J
Immunology; 2005 Sep; 116(1):103-11. PubMed ID: 16108822
[TBL] [Abstract][Full Text] [Related]
28. CD39+Foxp3+ regulatory T Cells suppress pathogenic Th17 cells and are impaired in multiple sclerosis.
Fletcher JM; Lonergan R; Costelloe L; Kinsella K; Moran B; O'Farrelly C; Tubridy N; Mills KH
J Immunol; 2009 Dec; 183(11):7602-10. PubMed ID: 19917691
[TBL] [Abstract][Full Text] [Related]
29. IL-17+ regulatory T cells in the microenvironments of chronic inflammation and cancer.
Kryczek I; Wu K; Zhao E; Wei S; Vatan L; Szeliga W; Huang E; Greenson J; Chang A; Roliński J; Radwan P; Fang J; Wang G; Zou W
J Immunol; 2011 Apr; 186(7):4388-95. PubMed ID: 21357259
[TBL] [Abstract][Full Text] [Related]
30. Adenosine and the adenosine A2A receptor agonist, CGS21680, upregulate CD39 and CD73 expression through E2F-1 and CREB in regulatory T cells isolated from septic mice.
Bao R; Shui X; Hou J; Li J; Deng X; Zhu X; Yang T
Int J Mol Med; 2016 Sep; 38(3):969-75. PubMed ID: 27430240
[TBL] [Abstract][Full Text] [Related]
31. p38 alpha mitogen-activated protein kinase is activated by CD28-mediated signaling and is required for IL-4 production by human CD4+CD45RO+ T cells and Th2 effector cells.
Schafer PH; Wadsworth SA; Wang L; Siekierka JJ
J Immunol; 1999 Jun; 162(12):7110-9. PubMed ID: 10358155
[TBL] [Abstract][Full Text] [Related]
32. A2A adenosine receptor may allow expansion of T cells lacking effector functions in extracellular adenosine-rich microenvironments.
Ohta A; Ohta A; Madasu M; Kini R; Subramanian M; Goel N; Sitkovsky M
J Immunol; 2009 Nov; 183(9):5487-93. PubMed ID: 19843934
[TBL] [Abstract][Full Text] [Related]
33. CD4+CD25+ regulatory T cells suppress contact hypersensitivity reactions through a CD39, adenosine-dependent mechanism.
Ring S; Oliver SJ; Cronstein BN; Enk AH; Mahnke K
J Allergy Clin Immunol; 2009 Jun; 123(6):1287-96.e2. PubMed ID: 19427686
[TBL] [Abstract][Full Text] [Related]
34. CD4+ Th2 cells function alike effector Tr1 and Th1 cells through the deletion of a single cytokine IL-6 and IL-10 gene.
Ankathatti Munegowda M; Xu S; Freywald A; Xiang J
Mol Immunol; 2012 Jun; 51(2):143-9. PubMed ID: 22424785
[TBL] [Abstract][Full Text] [Related]
35. The predominance of Th17 lymphocytes and decreased number and function of Treg cells in preeclampsia.
Darmochwal-Kolarz D; Kludka-Sternik M; Tabarkiewicz J; Kolarz B; Rolinski J; Leszczynska-Gorzelak B; Oleszczuk J
J Reprod Immunol; 2012 Mar; 93(2):75-81. PubMed ID: 22370101
[TBL] [Abstract][Full Text] [Related]
36. CCR8 expression identifies CD4 memory T cells enriched for FOXP3+ regulatory and Th2 effector lymphocytes.
Soler D; Chapman TR; Poisson LR; Wang L; Cote-Sierra J; Ryan M; McDonald A; Badola S; Fedyk E; Coyle AJ; Hodge MR; Kolbeck R
J Immunol; 2006 Nov; 177(10):6940-51. PubMed ID: 17082609
[TBL] [Abstract][Full Text] [Related]
37. CCR8 is expressed by antigen-elicited, IL-10-producing CD4+CD25+ T cells, which regulate Th2-mediated granuloma formation in mice.
Freeman CM; Chiu BC; Stolberg VR; Hu J; Zeibecoglou K; Lukacs NW; Lira SA; Kunkel SL; Chensue SW
J Immunol; 2005 Feb; 174(4):1962-70. PubMed ID: 15699124
[TBL] [Abstract][Full Text] [Related]
38. Effect of interleukin-15 on effector and regulatory function of anti-CD3/anti-CD28-stimulated CD4(+) T cells.
Lin SJ; Cheng PJ; Hsiao SS
Bone Marrow Transplant; 2006 May; 37(9):881-7. PubMed ID: 16565741
[TBL] [Abstract][Full Text] [Related]
39. CD4+ CD25+ [corrected] regulatory T cells render naive CD4+ CD25- T cells anergic and suppressive.
Qiao M; Thornton AM; Shevach EM
Immunology; 2007 Apr; 120(4):447-55. PubMed ID: 17244157
[TBL] [Abstract][Full Text] [Related]
40. Aging disturbs the balance between effector and regulatory CD4+ T cells.
van der Geest KS; Abdulahad WH; Tete SM; Lorencetti PG; Horst G; Bos NA; Kroesen BJ; Brouwer E; Boots AM
Exp Gerontol; 2014 Dec; 60():190-6. PubMed ID: 25449852
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
